Ignite Creation Date:
2024-05-05 @ 11:48 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00137735
Status:
COMPLETED
Last Update Posted:
2007-10-31
First Post:
2005-08-29
Brief Title:
Gabapentin for Carpal Tunnel Syndrome
Sponsor:
Chinese University of Hong Kong
Organization:
Chinese University of Hong Kong
Study Overview
Official Title:
Gabapentin for Carpal Tunnel Syndrome A Randomised Controlled Trial
Status:
COMPLETED
Status Verified Date:
2007-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine whether gabapentin is safe and effective in the treatment of carpal tunnel syndrome CTS
Detailed Description:
A variety of treatment options exist at present for carpal tunnel syndrome CTS with no universal agreement Recent reports suggested that untreated CTS might improve or remain stationary In this respect treatment directing towards symptom suppression alone may have a role in the initial management of CTS Gabapentin 1-aminomethyl-cyclohexaneacetic acid Neurontin Pfizer is an effective drug for treatment of neuropathic pain and has been reported to be effective in case series for the treatment of CTS with relatively benign side effects profile The purpose of this study was to evaluate the safety and efficacy of gabapentin in the treatment of CTS
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None